NCT03442673View on ClinicalTrials.gov

Chemotherapy and G-CSF for Mobilization

PHASE2CompletedINTERVENTIONAL
Enrollment

137

Participants

Timeline

Start Date

September 17, 2018

Primary Completion Date

March 1, 2023

Study Completion Date

May 1, 2024

Conditions
Multiple Myeloma
Interventions
DRUG

Vinorelbine

Stimulation with vinorelbine together with G-CSF for mobilization of autologous stem cells

DRUG

Gemcitabine

Stimulation with gemcitabine together with G-CSF for mobilization of autologous stem cells

DRUG

G-CSF

Cytokine stimulation with G-CSF for mobilization of autologous stem cells

Trial Locations (1)

3010

Department for Medical Oncology University Hospital/Inselspital, Bern

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT03442673 - Chemotherapy and G-CSF for Mobilization | Biotech Hunter | Biotech Hunter